CANCER THERAPY USING A DISUBSTITUTED BENZENE-ALKYNYL 3,5-COMPONED COMPOUND AND PEMBROLIZUMAB

MA55091AUndetermined Publication Date: 2022-01-05TAIHO PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA55091
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-06-18
Filing Date
2020-02-28
Publication Date
2022-01-05
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.